Target Name: LOC105371060
NCBI ID: G105371060
Review Report on LOC105371060 Target / Biomarker Content of Review Report on LOC105371060 Target / Biomarker
LOC105371060
Other Name(s): Uncharacterized LOC105371060, transcript variant X1 | LOC105371060 variant X1 | uncharacterized LOC105371060

LOC105371060: A Promising Drug Target and Biomarker

LOC105371060, also known as Uncharacterized LOC105371060 (UCL) or transcript variant X1, is a protein that has been identified as a potential drug target and biomarker. The protein is derived from the human iris and is expressed in the retina of the eye.

LOC105371060 is a member of the superfamily of transmembrane protein (SMP) family 7, which includes proteins involved in a variety of cellular processes, including intracellular signaling, neurotransmission, and vision. It is characterized by a unique open-loop structure, which allows it to form a disulfide bond and form a two-dimensional structure that is stable during cellular signaling.

Based on its unique structure and the involvement in cellular signaling, LOC105371060 is considered a promising drug target. The protein is known to play a role in the regulation of cell proliferation, differentiation, and survival, and is therefore considered a promising drug target. Drug target (or biomarker).

In cancer treatment, drug targeting LOC105371060 is considered an effective treatment. Studies have shown that LCK-1 is a gene related to lung cancer and is closely related to the progression and treatment response of lung cancer. Therefore, by inhibiting the activity of LCK-1, the growth and spread of lung cancer can be effectively inhibited. In addition, LOC105371060 has also been used as a drug target to treat other types of cancer, such as liver cancer, breast cancer, etc.

In addition to its use in cancer treatment, LOC105371060 may also play a role in the treatment of eye diseases. Because of its close association with retinal cells, it is considered a promising target for treating retinal diseases. Currently, some ophthalmic drugs, such as anti-diabetic drugs and anti-inflammatory drugs, have been developed to treat retinal diseases. However, these drugs often have certain side effects and cannot completely cure retinal diseases. Therefore, the development and utilization of LOC105371060 is expected to become a new and effective drug for the treatment of retinal diseases.

In addition, LOC105371060 is also related to some neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, etc. These diseases often result in the death of neurons and changes in neural circuits, leading to cognitive decline and movement impairment. Therefore, by inhibiting the activity of LOC105371060, these diseases can be effectively treated and the progression of neurodegenerative diseases can be slowed down.

In summary, LOC105371060 is a potential drug target (or biomarker) that can be used to treat various cancers, ophthalmic diseases, and neurodegenerative diseases. As technology continues to advance, research and development on LOC105371060 will continue to increase, bringing more hope to human health.

Protein Name: Uncharacterized LOC105371060

The "LOC105371060 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105371060 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105371061 | LOC105371068 | LOC105371069 | LOC105371072 | LOC105371081 | LOC105371082 | LOC105371097 | LOC105371114 | LOC105371116 | LOC105371160 | LOC105371164 | LOC105371230 | LOC105371268 | LOC105371269 | LOC105371274 | LOC105371275 | LOC105371276 | LOC105371278 | LOC105371279 | LOC105371308 | LOC105371347 | LOC105371356 | LOC105371371 | LOC105371388 | LOC105371401 | LOC105371413 | LOC105371427 | LOC105371441 | LOC105371442 | LOC105371444 | LOC105371446 | LOC105371449 | LOC105371461 | LOC105371465 | LOC105371468 | LOC105371470 | LOC105371475 | LOC105371483 | LOC105371487 | LOC105371497 | LOC105371513 | LOC105371522 | LOC105371529 | LOC105371536 | LOC105371611 | LOC105371614 | LOC105371642 | LOC105371649 | LOC105371655 | LOC105371661 | LOC105371664 | LOC105371665 | LOC105371671 | LOC105371675 | LOC105371692 | LOC105371701 | LOC105371702 | LOC105371719 | LOC105371720 | LOC105371730 | LOC105371744 | LOC105371749 | LOC105371767 | LOC105371770 | LOC105371773 | LOC105371775 | LOC105371776 | LOC105371793 | LOC105371800 | LOC105371801 | LOC105371814 | LOC105371829 | LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161